Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Respiratory syncytial virus

Recent news which mentions Respiratory syncytial virus

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags Health care industry GSK plc Business
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
Tags Science Respiratory syncytial virus Business News
From CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
Tags Biotech and Pharmaceuticals Biotechnology Science
From CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
Tags Pharmaceuticals Health & Science US: News
From CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
Tags Health care industry Business Breaking news
From CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
Tags Health care industry Business Breaking news
From CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
Tags Walgreens Boots Alliance Inc Pfizer Inc US: News
From CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Tags Health care industry Business GSK plc
From CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Tags Business GSK plc Health care industry
From CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
Tags Business News Respiratory syncytial virus Immunizations
From CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
Tags Business News Respiratory syncytial virus Immunizations
From CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
Tags GSK plc Business Health care industry
From CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
Tags Companies Breaking news Health care industry
From CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
Tags US: News Social issues Pfizer Inc
From CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
Tags Moderna Inc Business Health care industry
From CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Tags Companies Health care industry GSK plc
From CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
Tags Health & Science Pharmaceuticals Breaking News: Politics
From CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
Tags Policy Disease outbreaks Health & Science
From CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
Tags Vaccinations Immunizations Pfizer Inc
From CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
Tickers LIFE
Tags Lifestyle Tourism Business travel
From CNBC.com News
Why flu season is so bad this year
Tickers LIFE
Tags Science Respiratory syncytial virus Business News
From CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
Tags Policy Disease outbreaks Health & Science
From CNBC.com News
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
Tickers AZN AZNCF SNY
Tags Large Cap Biotech AZN
From Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
Tickers PFE
Tags Biotech REspiratory syncytial virus Briefs
From Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
Tickers JNJ
Tags General Health Care Biotech
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
Tickers JNJ
Tags Phase 2 Trial JNJ Market News
From Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
Tickers PFE
Tags Phase 3 Trial Health Care General
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.